The objective of this second renewal of the Integrated Biological Systems Training in Oncology (IBSTO) program is to continue to prepare predoctoral students and postdoctoral fellows for careers in cancer research with comprehensive training in basic and translational research. IBSTO training focuses on basic cellular processes and mechanisms that are shared between cell biology and developmental biology that are critical to understanding how cells become tumorigenic and on how to translate this basic research knowledge to the diagnosis, treatment and prevention of cancer. The IBSTO program takes place in an active and growing environment with state-of?the-art facilities, a vibrant NCI-designated comprehensive cancer center, top-ranked basic science departments, an Interdisciplinary Graduate Program in Biomedical Sciences, and an active Office of Postdoctoral Affairs. In our first nine years, we have recruited 42 outstanding predoctoral and postdoctoral trainees that have been very productive. Trainees have been placed with experienced, well-funded, productive preceptors in an interactive research environment with extensive resources. The three broad areas of experience of our preceptors are in cell biology, developmental biology/genetics and medicine. The goals of our training program are to provide proactive mentoring and oversight, provide cross-discipline education and research, provide training in cutting edge methodology, develop useful academic skills, foster interactions with faculty and other trainees, provide exposure to current cancer research discoveries, and provide exposure to clinical cancer treatment and translational research. In this renewal, we have strengthened our training activities by adding a new IBSTO Day Retreat, a new cross-disciplinary collaboration workshop, and bolstering our clinical/translational cohort of preceptors. We have also added a new External Advisory Board to provide ongoing feedback and evaluation of the program. And we have a new Program Director who has a strong record of basic cancer research and administrative experience. We believe that integrating basic science research training in cell biology, developmental biology and genetics with translational and clinical experience allows a better understanding of the multiple lesions in cellular processes that define cancer, which is critical to diagnosing, treating and eventually preventing of this disease.

Public Health Relevance

The Integrated Biological Systems Training in Oncology (IBSTO) program prepares predoctoral students and postdoctoral fellows for careers in cancer research with comprehensive training in basic and translational research. The IBSTO program takes place in an active biomedical research environment with state-of?the-art facilities, experienced preceptors in an interactive education and research environment with extensive resources and institutional commitment. The IBSTO program provides our productive trainees unique mentoring, useful academic skills, interactions with faculty and other trainees, exposure to current cancer research discoveries and exposure to clinical cancer treatment and translational research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
2T32CA119925-11
Application #
9571637
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Perkins, Susan N
Project Start
2018-09-01
Project End
2023-08-31
Budget Start
2018-09-01
Budget End
2019-08-31
Support Year
11
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
965717143
City
Nashville
State
TN
Country
United States
Zip Code
37240
Norris, Stephen R; Jung, Seungyeon; Singh, Prashant et al. (2018) Microtubule minus-end aster organization is driven by processive HSET-tubulin clusters. Nat Commun 9:2659
Chiang, Yun-Chen; Park, In-Young; Terzo, Esteban A et al. (2018) SETD2 Haploinsufficiency for Microtubule Methylation Is an Early Driver of Genomic Instability in Renal Cell Carcinoma. Cancer Res 78:3135-3146
Lawrence, Elizabeth J; Arpag, Göker; Norris, Stephen R et al. (2018) Human CLASP2 specifically regulates microtubule catastrophe and rescue. Mol Biol Cell 29:1168-1177
Willet, Alaina H; Bohnert, K Adam; Gould, Kathleen L (2018) Cdk1-dependent phosphoinhibition of a formin-F-BAR interaction opposes cytokinetic contractile ring formation. Mol Biol Cell 29:713-721
Elmore, Zachary C; Guillen, Rodrigo X; Gould, Kathleen L (2018) The kinase domain of CK1 enzymes contains the localization cue essential for compartmentalized signaling at the spindle pole. Mol Biol Cell 29:1664-1674
Jones, Christine M; Chen, Jun-Song; Johnson, Alyssa E et al. (2018) Relief of the Dma1-mediated checkpoint requires Dma1 autoubiquitination and dynamic localization. Mol Biol Cell 29:2176-2189
Choi, Eunyoung; Lantz, Tyler L; Vlacich, Gregory et al. (2018) Lrig1+ gastric isthmal progenitor cells restore normal gastric lineage cells during damage recovery in adult mouse stomach. Gut 67:1595-1605
Lee, Sora; Tumolo, Jessica M; Ehlinger, Aaron C et al. (2017) Ubiquitin turnover and endocytic trafficking in yeast are regulated by Ser57 phosphorylation of ubiquitin. Elife 6:
Seldin, Lindsey; Macara, Ian (2017) Epithelial spindle orientation diversities and uncertainties: recent developments and lingering questions. F1000Res 6:984
Sai, Jiqing; Owens, Philip; Novitskiy, Sergey V et al. (2017) PI3K Inhibition Reduces Mammary Tumor Growth and Facilitates Antitumor Immunity and Anti-PD1 Responses. Clin Cancer Res 23:3371-3384

Showing the most recent 10 out of 134 publications